5-Year Rate Changes > Interpret
Interpretation of 5-Year Rate Changes Data
5-Year Rate Changes - MortalityBar graph with 20 items
Ages <50, Both Sexes, All Races (incl Hisp)
Since the overall trend is negative (-2.10 with a 95% confidence interval from -2.40 to -1.70 ), the overall cancer rate is falling.
The following cancers could not be calculated due to insufficient counts:
- Brain & ONS
- Kidney & Renal Pelvis
- Liver & Bile Duct
- Melanoma of the Skin
- Non-Hodgkin Lymphoma
- Oral Cavity & Pharynx
- Ovary (Female)
- Prostate (Male)
- Uterus (Corp/Uterus NOS) (Fem)
Rising when 95% confidence interval of annual percent change is above 0.
The rate for the following cancers rose in the time period:
- Colon & Rectum with a trend of 1.1# and a 95% confidence interval from 0.1 to 2.2.
Falling when 95% confidence interval of annual percent change is below 0.
The rate for the following cancers fell in the time period:
- Lung & Bronchus with a trend of -5.6# and a 95% confidence interval from -6.4 to -4.8.
- Cervix (Female) with a trend of -1.6# and a 95% confidence interval from -3.0 to -0.2.
- Breast (Female) with a trend of -1.5# and a 95% confidence interval from -2.4 to -0.6.
Created by statecancerprofiles.cancer.gov on 07/25/2021 12:59 pm.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat . Death rates (deaths per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data File is used with mortality data.
AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The 1969-2017 US Population Data File is used with SEER November 2017 data. Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html. Please note that the data comes from different sources. Due to different years of data availablility, most of the trends are AAPCs based on APCs but some are EAPCs calculated in SEER*Stat. Please refer to the source for each graph for additional information.